Matthew Phipps

Item: Matthew Phipps
Rating: 0.39
Author: StockAnalysis.com

Stock Analyst at William Blair

(0.39)

# 4,259

Out of 5,099 analysts

Total ratings

n/a

Success rate

-6.7%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Matthew Phipps

Stock	Action	Price Target	Current	Upside	Ratings	Updated
NCNA NuCana	Downgrades: Market Perform	n/a	$4.33	-	1	Aug 30, 2024
AMGN Amgen	Upgrades: Outperform	n/a	$315.22	-	1	May 3, 2024
NAMS NewAmsterdam Pharma Company	Initiates: Outperform	n/a	$35.34	-	1	Dec 19, 2022

NuCana

Aug 30, 2024

Downgrades: Market Perform

Price Target: n/a

Current: $4.33

Upside: -

Amgen

May 3, 2024

Upgrades: Outperform

Price Target: n/a

Current: $315.22

Upside: -

NewAmsterdam Pharma Company

Dec 19, 2022

Initiates: Outperform

Price Target: n/a

Current: $35.34

Upside: -